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Hypertrophic scar has always been the top priority of
post-burn intervention. Specialists from multiple disci-
plines have dedicated enormous efforts expanding the
knowledge in understanding the etiology of hypertrophic
scar formation and establishing the scientific evidence of
effective management of hypertrophic scar. The devotion
and pursuit of these scientists and clinicians has been
especially meaningful for the population in Asia since it
has been well proven that hypertrophic scar was endemic
to the Asian population comparing to the Caucasians.
Besides early intervention, functional outcomes and long-
term quality of life for people with extensive burn injuries
have been investigated by different researchers and further
substantiate the importance of long-term continuum of
rehabilitation programs [1, 2].
In Asian countries such as China, management of
hypertrophic scar is mainly confined to surgical removal
of scar causing contracture, deformities, and/or disfigure-
ment. Early and active scar management is rarely prac-
ticed soon after surgical implementation. Thus, functional
outcomes are expected to be poor. In the past two de-
cades, burn specialists have begun to realize the import-
ance of functional outcome of patients with massive burns
in China [3]. New evidence regarding the quality of life of
patients with extensive burn injuries identified a poorer
quality of life with prolonged physical and psychological
problems. Fortunately, there is a positive trend of gradual
improvements noted but slow [2]. As the socio-economic
boost of the society and the advancement in the quality
and standards of medical care, the ultimate goal of post-
burn management has been shifting from survival to func-
tional recovery, since both the patient and the health care
professional gradually strive for a better quality of life with
social re-integration.
The thorough understanding of etiological and molecular
basis of hypertrophic scar formation has been considered
as the foundation of effective prevention and management
of hypertrophic scar. In this special issue, Zhu, Ding, and
Tredget [4] conducted comprehensive review on the mo-
lecular basis of hypertrophic scars, highlighting the roles of
cytokines, growth factors, and macrophages via chemokine
pathways. In Tan et al.’s recent article [5], novel technology
of isobaric tags for relative and absolute quantitation
(iTRAQ) was applied in order to advance our exploration
on the various mechanisms and cellular signaling pass
ways of hypertrophic scar formation. The comprehensive
investigation identified multiple up-regulated and down-
regulated proteins, which might serve as indicators for fu-
ture management strategies.
Along with the advocacy of evidence-based medicine,
international burn society has gradually recognized the im-
portance of research evidence in guiding clinical practice.
Several international guidelines have been published in re-
cent years based on extensive literature reviews. Despite
the limited research design and inadequacy of clinical data
available, consensus in several areas on scar management
was finalized and new intervention strategies could be ex-
plored [6, 7]. Interestingly, despite the relatively adequacy
of the literature supporting the effectiveness of silicone gel
and emergence of all the alternative interventions, a survey
of burn centers across North America and Australia sug-
gested that the most common intervention are still splint-
ing, postoperative ambulation, conditioning, scar massage,
and use of compression garments [8].
In accordance with the International Society for Burn
Injuries, the first Guidelines for Burn Rehabilitation in
China has been published by the Chinese Burn Associ-
ation, Chinese Association of Burn Surgeons, and The
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Chinese Burn Care and Rehabilitation Association in
2015. In this guideline, the concept of early intervention
was strongly advocated to all practicing therapists in burn
management. For scar management, pressure therapy, sili-
cone gel sheets, massage, and intralesional injection were
suggested [9].
China was not the only country that recognized the
predominance of hypertrophic scar in Asian population.
In 2013, a guideline of scar management especially tar-
geting Asian patients was published based on literature
review and a panel of experts’ opinions. The guideline not
only stressed on the importance of early intervention, but
also advocated on scar prevention. Unlike the rather
conservative Chinese guidelines, a wide variety of novel
modalities were introduced and evaluated on their clinical
efficacy, namely, intralesional steroid injections, radiation
therapy, and intralesional 5-fluorouracil injections. Laser
treatment and surgical removal were also proposed as the
last resort on scar management. Unlike international guide-
lines, this panel of experts did not recommend pressure
therapy as the mainstay of scar management [10].
One of the possible reasons for the discordance of afore-
mentioned different expert panels may be due to the di-
verse and subjective scar measurements on the clinical
outcomes of various intervention modalities. Fortunately,
the concept of standardized objective scar assessments has
been strongly advocated in the past decade from research
institutions to clinical settings. In this special issue, a
systematic review which featured exclusively on objective
scar measurements was presented by Lee and his team in
UK [11]. Despite the escalation in the quantity of objective
scar assessments, inconsistent evidence of the quality of
these objective scar assessments demands further investiga-
tions and refinements. Nonetheless, the recommendations
proposed in this paper could offer us various promising
options to measure different dimensions of scar objectively
and accurately. Thus, more evidence could be scientifically
supported on different intervention regime.
Another obstacle towards consensus may be due to
the inadequate and the inconsistent clinical evidence
available, especially for the expanding numbers of novel
treatment methods. This time, two categories of scar
treatment will be addressed, one is intralesional injection
and another is natural therapeutics. Intralesional injection
of various therapeutic agents including triamcinolone,
bleomycin, 5-fluorouracil, verapamil, was among the most
popular options in scar treatment in the recent decade.
However, Trisliana Perdanasari et al. [12] revealed that
extra discretion was required for decision making in using
intralesional injection due to sparse evidence at present.
Comparing to intralesional injections, natural therapeutics
gained reputation from practitioners and researchers due
to non-invasive nature. In the review conducted by Rolfe et
al. [13] both plant-based product and nonplant-based
therapeutics were explored and evaluated based on in vivo
and in vitro experiments. Clearly, these fascinating fields
show great potential which enchant us for further
exploration.
In addition, preventive measures against hypertrophic
scarring were not only taken after the wound closure. It
is widely accepted that prolonged wound healing would
induce abnormal scar formation; thus, one key factor to
prevent formation of hypertrophic scar is to facilitate
early wound closure. Innovative technology of tissue en-
gineering is important to enhance early wound healing.
Two papers on comprehensive review of hypertrophic
scar and its management are presented in this special
issue. The article by van Zuijlen et al. [14] provided in-
depth evaluation on not only skin substitutes, but also
subcutaneous fat tissue and cartilage. While Chua and his
colleagues [15] will guide us through the history of skin
tissue engineering, from the initial development to up-to-
dated advancement of dermal substitutes implementation
methods available to clinicians. Through combining the
knowledge together, we hope that we can offer a holistic
picture of tissue engineering for practitioners working in
the field of burn and scar management and promoting
healing of wounds through skin tissue engineering.
In 2014, a national survey was conducted in China on
burn rehabilitation services, in which several challenging is-
sues facing China burn society were pointed out, highlight-
ing the importance of professional development and
specialist education [16]. With the aforementioned national
guideline published, the Chinese Burn Society has no doubt
striding out the first step. Hopefully, this special issue will
further enhance the reader’s understanding on the most up-
dated scar management practice, thus inspiring further
research in management of hypertrophic scar. Our vision is
first to create a “scar-less world”, then to the “scarless
world”.
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